Winway Health Desk
Henry Ford Health Plans Two Projects In Detroit
Henry Ford Health (Detroit) announced plans for two new projects in Detroit: the Shirley Ryan AbilityLab and the Nick Gilbert Neurofibromatosis Research Institute.
Expected to...
The HCD 10: Corey Gaarde, Building Professional
Corey Gaarde, principal, project executive, IMEG (Naperville, Ill.)
As a principal and project executive at IMEG, Corey Gaarde leads the Healthcare Information Technology (HIT) Advisory...
FDA Approves Aphexda (motixafortide) to Mobilize Hematopoietic Stem Cells for Autologous...
FDA Approves Aphexda (motixafortide) to Mobilize Hematopoietic Stem Cells for Autologous Transplantation in Patients with Multiple MyelomaAphexda is the first innovation in stem cell...
FDA Approves Updated Covid-19 Vaccines to Address Now Circulating Variants
Two updated Covid-19 vaccines based on messenger RNA technology now have the FDA’s regulatory nod, setting the stage for the new shots to become...
FDA Approves Aphexda (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize...
FDA Approves Aphexda (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Patients with Multiple...
Health Wildcatters Takes The Wraps Off Its Latest Cohort of Healthcare...
Health Wildcatters has launched the latest cohort of healthcare startups, bringing its total number of portfolio companies to 109 in the 11th year for...
Pumpspotting Secures $2.2M To Expand Access to Breastfeeding Support
Amy VanHaren, founder and CEO of breastfeeding support platform pumpspotting, first came up with the idea for her company while sitting on a “dirty...
Jamal Browner Nearly Pulls 510 Kilograms (1,124 Pounds), Approaching Heaviest Deadlift...
Browner continues to showcase his dominant pulling.Written by Chris Colucci Last updated on September 11, 2023Jamal Browner has made a name for himself as...
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
This season’s vaccine is tailored to the SARS-CoV-2 XBB.1.5 sublineage and indicated as a single dose for most individuals 5 years of age and...
Moderna Puts Up $120M to Start Cancer Drug R&D Alliance With...
Moderna already has messenger RNA-based cancer vaccines in clinical development, but it wants to see if the T cell technology of immunotherapy developer Immatics...
